AAAAAA

   
Results: 1-8 |
Results: 8
THE SIGNALING PATHWAY FOR INDUCTION OF COLLAGENASE-1 GENE-EXPRESSION IN RABBIT SYNOVIAL FIBROBLASTS INDUCED BY PHAGOCYTOSIS OF PARTICLES COATED WITH INTEGRIN LIGANDS IS TEMPERATURE-SENSITIVE
Authors: WILLIAMSHERMAN D WERB Z
Citation: D. Williamsherman et Z. Werb, THE SIGNALING PATHWAY FOR INDUCTION OF COLLAGENASE-1 GENE-EXPRESSION IN RABBIT SYNOVIAL FIBROBLASTS INDUCED BY PHAGOCYTOSIS OF PARTICLES COATED WITH INTEGRIN LIGANDS IS TEMPERATURE-SENSITIVE, Molecular biology of the cell, 9, 1998, pp. 1735-1735
A DILEUCINE MOTIF IN HIV-1 NEF ACTS AS AN INTERNALIZATION SIGNAL FOR CD4 DOWN-REGULATION AND BINDS THE AP-1 CLATHRIN ADAPTER
Authors: BRESNAHAN PA YONEMOTO W FERRELL S WILLIAMSHERMAN D GELEZIUNAS R GREENE WC
Citation: Pa. Bresnahan et al., A DILEUCINE MOTIF IN HIV-1 NEF ACTS AS AN INTERNALIZATION SIGNAL FOR CD4 DOWN-REGULATION AND BINDS THE AP-1 CLATHRIN ADAPTER, Current biology, 8(22), 1998, pp. 1235-1238
TRANSIENT HYPOGAMMAGLOBULINEMIA OF INFANCY (THI) AND VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS (VAPP)
Authors: DORENBAUM A WILLIAMSHERMAN D ELDER ME SHAMES RS WARA DW
Citation: A. Dorenbaum et al., TRANSIENT HYPOGAMMAGLOBULINEMIA OF INFANCY (THI) AND VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS (VAPP), Journal of allergy and clinical immunology, 99(1), 1997, pp. 719-719
DEFICIENCY PRESENTING WITH ESCHERICHIA-COLI SEPSIS AND BRAIN-ABSCESS IN THE NEONATAL-PERIOD
Authors: AVILA PC DORENBAUM A WILLIAMSHERMAN D ELDER ME SHAMES RS WARA DW
Citation: Pc. Avila et al., DEFICIENCY PRESENTING WITH ESCHERICHIA-COLI SEPSIS AND BRAIN-ABSCESS IN THE NEONATAL-PERIOD, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1612-1612
RANDOMIZED STUDY OF THE TOLERANCE AND EFFICACY OF HIGH-DOSE VERSUS LOW-DOSE ZIDOVUDINE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN WITH MILD-TO-MODERATE SYMPTOMS (AIDS CLINICAL-TRIALS GROUP 128)
Authors: BRADY MT MCGRATH N BROUWERS P GELBER R FOWLER MG YOGEV R HUTTON N BRYSON YJ MITCHELL CD FIKRIG S BORKOWSKY W JIMENEZ E MCSHERRY G RUBINSTEIN A WILFERT CM MCINTOSH K ELKINS MM WEINTRUB PS BERNSTEIN L SHLIOZBERG J LIVINGSTON RA VINK P FLAUTT L KLINE MW RAYBORN T KAUL A LAWRENCE R CHANDWANI S RUBINHALE A KNOXBURKE K ALATTAR I COOPER ER PELTON SI REGAN AM DAMON B YOUNG B NOZYCE M CIHAK P WIZNIA A CHADWICK EG SILIO M KLAUKE BJ OLESKE JM COLABELLI NB CONNOR EM GERSHON A PITT J SHEA K CLARK P CERVIA JS EDELSON PJ SANDERSLAUFER D HINDS GA RAKUSAN TA SEVER J HERZOG K ELLAURIE M MCKINNEY RE LANE BA SANTACROCE S NESHEIM SR SAWYER M SARVER J MEADOWS L ABRAMS E KANEM N FRERE M URBANO R RAGNI MV MILLER B CARFAGNA E MENDEZ H HANDLESMAN E DIFILIPPO G BERGIN HF SHAH K RAO S VILLARICA NC CLINTRON AA HODES D BARZELAI A BUTLER L HEATON S GUPTA A AHERN L MUNOZ J LI K BAMJI M KENNEDY G DUMMITT M PAHWA S BAKSJI S HUNKLER JA CALLAWAY CC CRIM LB DIAZ C RIVERA C FLORES L BEAUCHAMP B DIAZ L AGUAYO R GARCIATRIAS DE FRENKEL LD GAUR S SCUDDER RC KECHULA IM LISCHNER HW GREGONIS SW TRESTON CS RAPHAEL SA CARRER MT PEREZ L BERRIOS Z BURCHETT SK MELVIN AJ COREY L MOHAN KM GRIECO M MCKINLEY G RIVERA J MOALLEN H SCHULLER G PRAMBERG JC ALCHEDIAK T VANDYKE RB CALLIGARO D CHURCH J DEVEIKIS A GILETTE S SPECTOR SA DANKNER WM INSTONE S STANGLE L WARA DW PETRU A WILLIAMSHERMAN D BAKER RC SIEGEL R MCOWEN N ROBINSON J WELLS L JOHNSON GM RICH KC HAYANI K TURPIN D SULLIVAN JL LUZURIAGA K STECHENBERG BW ROBINSON JE LIM W DUDEK V MUNDORF L SANTUCCI S FRENKEL L LAMBERT JS MURANTE B SCOTT GB GOURLEY J MENDOZA C DOYLE M CANTINI M
Citation: Mt. Brady et al., RANDOMIZED STUDY OF THE TOLERANCE AND EFFICACY OF HIGH-DOSE VERSUS LOW-DOSE ZIDOVUDINE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN WITH MILD-TO-MODERATE SYMPTOMS (AIDS CLINICAL-TRIALS GROUP 128), The Journal of infectious diseases, 173(5), 1996, pp. 1097-1106
GENE-THERAPY FOR NEONATES WITH ADA DEFICIENCY BY TRANSFER OF THE HUMAN ADA CDNA INTO UMBILICAL-CORD CD34-YEAR FOLLOW-UP( CELLS 2)
Authors: KOHN DB WEINBERG KI LENARSKY C CROOKS G HEISS LN NOLTA JA WARA D ELDER M WILLIAMSHERMAN D BOWEN T MOEN RC BLAESE RM
Citation: Db. Kohn et al., GENE-THERAPY FOR NEONATES WITH ADA DEFICIENCY BY TRANSFER OF THE HUMAN ADA CDNA INTO UMBILICAL-CORD CD34-YEAR FOLLOW-UP( CELLS 2), Pediatric research, 37(4), 1995, pp. 9-9
GENE-THERAPY FOR NEONATES WITH ADENOSINE-DEAMINASE (ADA) DEFICIENT SCID BY RETROVIRAL-MEDIATED TRANSFER OF THE HUMAN ADA CDNA INTO UMBILICAL-CORD CD34+ CELLS
Authors: KOHN DB WEINBERG KI LENARSKY C CROOKS GM HANLEY ME LAWRENCE K ANNETT G BROOKS JS WARA D ELDER M WILLIAMSHERMAN D BOWEN T HERSHFIELD MS BERENSON RI MOEN RC MULLEN CA BLAESE RM PARKMAN R
Citation: Db. Kohn et al., GENE-THERAPY FOR NEONATES WITH ADENOSINE-DEAMINASE (ADA) DEFICIENT SCID BY RETROVIRAL-MEDIATED TRANSFER OF THE HUMAN ADA CDNA INTO UMBILICAL-CORD CD34+ CELLS, Pediatric research, 35(4), 1994, pp. 10000152-10000152
ASSOCIATION BETWEEN ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY ANTIBODY-TITERS AT BIRTH AND VERTICAL TRANSMISSION OF HIV-1
Authors: JENKINS M LANDERS D WILLIAMSHERMAN D WARA D VISCARELLO RR HAMMILL HA KLINE MW SHEARER WT CHARLEBOIS ED KOHL S
Citation: M. Jenkins et al., ASSOCIATION BETWEEN ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY ANTIBODY-TITERS AT BIRTH AND VERTICAL TRANSMISSION OF HIV-1, The Journal of infectious diseases, 170(2), 1994, pp. 308-312
Risultati: 1-8 |